National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report AH Filipovich, D Weisdorf, S Pavletic, G Socie, JR Wingard, SJ Lee, ... Biology of blood and marrow transplantation 11 (12), 945-956, 2005 | 4294 | 2005 |
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working … MH Jagasia, HT Greinix, M Arora, KM Williams, D Wolff, EW Cowen, ... Biology of Blood and Marrow Transplantation 21 (3), 389-401. e1, 2015 | 2876 | 2015 |
Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference H Northrup, DA Krueger, S Roberds, K Smith, J Sampson, B Korf, ... Pediatric neurology 49 (4), 243-254, 2013 | 1685 | 2013 |
Activated STING in a vascular and pulmonary syndrome Y Liu, AA Jesus, B Marrero, D Yang, SE Ramsey, ... New England Journal of Medicine 371 (6), 507-518, 2014 | 1331 | 2014 |
An autoinflammatory disease with deficiency of the interleukin-1–receptor antagonist I Aksentijevich, SL Masters, PJ Ferguson, P Dancey, J Frenkel, ... New England Journal of Medicine 360 (23), 2426-2437, 2009 | 1085 | 2009 |
Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference DA Krueger, H Northrup, S Roberds, K Smith, J Sampson, B Korf, ... Pediatric neurology 49 (4), 255-265, 2013 | 933 | 2013 |
Early-onset stroke and vasculopathy associated with mutations in ADA2 Q Zhou, D Yang, AK Ombrello, AV Zavialov, C Toro, AV Zavialov, ... New England Journal of Medicine 370 (10), 911-920, 2014 | 873 | 2014 |
GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity MA Spinner, LA Sanchez, AP Hsu, PA Shaw, CS Zerbe, KR Calvo, ... Blood, The Journal of the American Society of Hematology 123 (6), 809-821, 2014 | 749 | 2014 |
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies GAM Sanchez, A Reinhardt, S Ramsey, H Wittkowski, PJ Hashkes, ... The Journal of clinical investigation 128 (7), 3041-3052, 2018 | 505 | 2018 |
Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations H Northrup, ME Aronow, EM Bebin, J Bissler, TN Darling, PJ de Vries, ... Pediatric Neurology 123, 50-66, 2021 | 491 | 2021 |
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic … SZ Pavletic, P Martin, SJ Lee, S Mitchell, D Jacobsohn, EW Cowen, ... Biology of Blood and Marrow Transplantation 12 (3), 252-266, 2006 | 472 | 2006 |
Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia DC Vinh, SY Patel, G Uzel, VL Anderson, AF Freeman, KN Olivier, ... Blood, The Journal of the American Society of Hematology 115 (8), 1519-1529, 2010 | 389 | 2010 |
Cutaneous drug reactions CK Svensson, EW Cowen, AA Gaspari Pharmacological reviews 53 (3), 357-379, 2001 | 294 | 2001 |
Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole EW Cowen, JC Nguyen, DD Miller, D McShane, ST Arron, NS Prose, ... Journal of the American Academy of Dermatology 62 (1), 31-37, 2010 | 266 | 2010 |
Chronic granulomatous disease as a risk factor for autoimmune disease SS De Ravin, N Naumann, EW Cowen, J Friend, D Hilligoss, ... Journal of allergy and clinical immunology 122 (6), 1097-1103, 2008 | 265 | 2008 |
Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease SR Hymes, AM Alousi, EW Cowen Journal of the American Academy of Dermatology 66 (4), 535. e1-535. e16, 2012 | 176 | 2012 |
Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity DD Miller, EW Cowen, JC Nguyen, TH McCalmont, LP Fox Archives of dermatology 146 (3), 300-304, 2010 | 172 | 2010 |
A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixafor DH McDermott, Q Liu, D Velez, L Lopez, S Anaya-O’Brien, J Ulrick, ... Blood, The Journal of the American Society of Hematology 123 (15), 2308-2316, 2014 | 164 | 2014 |
Cutaneous manifestations of DOCK8 deficiency syndrome EY Chu, AF Freeman, H Jing, EW Cowen, J Davis, HC Su, SM Holland, ... Archives of dermatology 148 (1), 79-84, 2012 | 163 | 2012 |
Autoinflammatory pustular neutrophilic diseases HB Naik, EW Cowen Dermatologic clinics 31 (3), 405-425, 2013 | 152 | 2013 |